Antero Midstream Announces Third Quarter 2026 Financial and Operating Results

Antero Midstream reported Q3 2026 net income of $393 million, or $0.82 per diluted share, up 242% year over year; results included a $377 million litigation gain. Adjusted EBITDA rose 3% to $291 million, while gathering and compression volumes increased 19% and 17%, respectively, and capital expenditures were flat at $51 million. The company raised 2026 adjusted free cash flow guidance before and after dividends by $370 million due to the litigation proceeds; it also reduced debt by more than $400 million during the quarter and repurchased 1.3 million shares for about $27 million. Antero expects 15–20 Bcf of throughput curtailments in Q4 2026.

Analysis

AM’s headline cash-flow uplift is predominantly a one-off litigation receipt, not a higher recurring earnings run rate. The cleaner signal is modest EBITDA growth alongside much faster gathering-volume growth: investors should not capitalize throughput growth without evidence that it converts into durable incremental EBITDA. The upcoming call should clarify the contribution from the acquired water system, new compression, and mix; cost-plus water services may expand activity without comparable margin expansion.

Near term, the 15–20 Bcf of expected Q4 curtailments could blunt the benefit of new capacity and delay the promised growth into 2027. This is also a concentrated-customer exposure: AM’s growth depends heavily on Antero Resources’ drilling pace and ability to move production. The integration and pad ramp are execution catalysts over the next 1–3 quarters; over 6–18 months, sustained throughput and EBITDA conversion matter more than the litigation-funded cash return. Buybacks can support per-share results, but the finite proceeds should not be mistaken for recurring coverage.

The contrarian risk is that investors treat volume growth and the litigation-driven guidance reset as evidence of a step-change in cash generation. Conversely, the market may underappreciate the value of new capacity if integration delivers and curtailments ease. Verify recurring FCF excluding litigation, segment EBITDA contribution, and post-repurchase leverage. Thesis weakens if EBITDA fails to accelerate after integration, curtailments exceed guidance, or AR slows its development program.

Key Decisions for Investors

• Avoid extrapolating the revised FCF guidance as recurring. For AM, assess valuation and dividend/buyback capacity against cash flow excluding the litigation proceeds.
• Watch the October 29 call for quantified EBITDA contribution from the water-system integration, the two growth pads, and 80 MMcf/d of compression. Treat management’s 2027 growth outlook as a catalyst, not yet a confirmed earnings run rate.
• Near term, keep AM exposure measured until Q4 curtailments and integration execution are clearer. A sustained EBITDA step-up after year-end would support adding; flat EBITDA despite higher volumes would falsify the conversion thesis.
• Track AR’s drilling and completion pace as the key demand-side indicator for AM. Any slowdown or deeper-than-guided curtailments would threaten the expected ramp and could make buyback-led per-share growth less durable.